109 related articles for article (PubMed ID: 21942515)
1. Dynamic range compression: a solution for proteomic biomarker discovery?
Griffin TJ; Bandhakavi S
Bioanalysis; 2011 Sep; 3(18):2053-6. PubMed ID: 21942515
[No Abstract] [Full Text] [Related]
2. Review of a current role of mass spectrometry for proteome research.
Chen CH
Anal Chim Acta; 2008 Aug; 624(1):16-36. PubMed ID: 18706308
[TBL] [Abstract][Full Text] [Related]
3. Role of proteomics in the discovery of autism biomarkers.
Al-Ayadhi L; Halepoto DM
J Coll Physicians Surg Pak; 2013 Feb; 23(2):137-43. PubMed ID: 23374519
[TBL] [Abstract][Full Text] [Related]
4. Body fluid proteomics for biomarker discovery: lessons from the past hold the key to success in the future.
Good DM; Thongboonkerd V; Novak J; Bascands JL; Schanstra JP; Coon JJ; Dominiczak A; Mischak H
J Proteome Res; 2007 Dec; 6(12):4549-55. PubMed ID: 17970587
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in mass spectrometry-based peptidome analysis.
Hu L; Ye M; Zou H
Expert Rev Proteomics; 2009 Aug; 6(4):433-47. PubMed ID: 19681678
[TBL] [Abstract][Full Text] [Related]
6. Application of proteomic technologies for prostate cancer detection, prognosis, and tailored therapy.
Fredolini C; Liotta LA; Petricoin EF
Crit Rev Clin Lab Sci; 2010; 47(3):125-38. PubMed ID: 20858067
[TBL] [Abstract][Full Text] [Related]
7. Shotgun proteomics: integrating technologies to answer biological questions.
McDonald WH; Yates JR
Curr Opin Mol Ther; 2003 Jun; 5(3):302-9. PubMed ID: 12870441
[TBL] [Abstract][Full Text] [Related]
8. Proteomic applications of protein quantification by isotope-dilution mass spectrometry.
Mayya V; K Han D
Expert Rev Proteomics; 2006 Dec; 3(6):597-610. PubMed ID: 17181474
[TBL] [Abstract][Full Text] [Related]
9. Overcoming the dynamic range problem in mass spectrometry-based shotgun proteomics.
Wu L; Han DK
Expert Rev Proteomics; 2006 Dec; 3(6):611-9. PubMed ID: 17181475
[TBL] [Abstract][Full Text] [Related]
10. Mass spectrometry-coupled techniques for viral-related disease biomarker identification.
Rhea JM; Diwan CA; Molinaro RJ
Biomark Med; 2010 Dec; 4(6):859-70. PubMed ID: 21133707
[TBL] [Abstract][Full Text] [Related]
11. Application of a peptide-based PF2D platform for quantitative proteomics in disease biomarker discovery.
Lee HJ; Kang MJ; Lee EY; Cho SY; Kim H; Paik YK
Proteomics; 2008 Aug; 8(16):3371-81. PubMed ID: 18651672
[TBL] [Abstract][Full Text] [Related]
12. Advances in membranous vesicle and exosome proteomics improving biological understanding and biomarker discovery.
Raimondo F; Morosi L; Chinello C; Magni F; Pitto M
Proteomics; 2011 Feb; 11(4):709-20. PubMed ID: 21241021
[TBL] [Abstract][Full Text] [Related]
13. High resolution proteome/peptidome analysis of body fluids by capillary electrophoresis coupled with MS.
Schiffer E; Mischak H; Novak J
Proteomics; 2006 Oct; 6(20):5615-27. PubMed ID: 16991199
[TBL] [Abstract][Full Text] [Related]
14. Clinical proteomics: the promises and challenges of mass spectrometry-based biomarker discovery.
deVera IE; Katz JE; Agus DB
Clin Adv Hematol Oncol; 2006 Jul; 4(7):541-9. PubMed ID: 17147241
[TBL] [Abstract][Full Text] [Related]
15. CE-MS in biomarker discovery, validation, and clinical application.
Mischak H; Schanstra JP
Proteomics Clin Appl; 2011 Feb; 5(1-2):9-23. PubMed ID: 21280234
[TBL] [Abstract][Full Text] [Related]
16. Advanced proteomic technologies for cancer biomarker discovery.
Wong SC; Chan CM; Ma BB; Lam MY; Choi GC; Au TC; Chan AS; Chan AT
Expert Rev Proteomics; 2009 Apr; 6(2):123-34. PubMed ID: 19385940
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in capillary electrophoresis-based proteomic techniques for biomarker discovery.
Fang X; Balgley BM; Lee CS
Electrophoresis; 2009 Dec; 30(23):3998-4007. PubMed ID: 19960464
[TBL] [Abstract][Full Text] [Related]
18. Employment of complementary dissociation techniques for body fluid characterization and biomarker discovery.
Good DM; Rutishauser D
Methods Mol Biol; 2013; 1002():223-32. PubMed ID: 23625407
[TBL] [Abstract][Full Text] [Related]
19. Sample preparation and fractionation for proteome analysis and cancer biomarker discovery by mass spectrometry.
Ahmed FE
J Sep Sci; 2009 Mar; 32(5-6):771-98. PubMed ID: 19219839
[TBL] [Abstract][Full Text] [Related]
20. Plasma-derived microparticles for biomarker discovery.
Smalley DM; Ley K
Clin Lab; 2008; 54(3-4):67-79. PubMed ID: 18630736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
